CAPVAXIVE
CAPVAXIVE
Approved
DIN Number
02549891
Drug Class
Human
Market Date
Aug 29, 2024
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02549891
AIG Number2266063001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AL02 PNEUMOCOCCUS, PURIFIED POLYSACC.ANTIGEN CONJUGATED
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (22)
CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEINActive
Strength: 65 MCG / 0.5 ML
Monograph: CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 16FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 16F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23BActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23B
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 24FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 24F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3Active
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 31Active
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 31
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 35BActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 35B
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6AActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7FActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8Active
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9NActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE DEOAC15BActive
Strength: 4 MCG / 0.5 ML
Monograph: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE DEOAC15B